Inteum Company
Links
seedsprint
Visible Legacy
RSS
News & Resources
Inteum Company News
Inteum Library
Subscribe
Expression of Human Isoferritins
Case ID:
250-2074
Web Published:
5/13/2025
A technology that can express and purify a variety of human heteropolymer isoferritins of various ratios. Background: Ferritin is a molecule resent in mammals, which serves the primary function of sequestering ferrous iron and inducing its mineralization. In mammals, and most saliently in humans, ferritins exist as a co-assembled heteropolymers. Ferritin is produced/extracted using two primary methods: (1) extraction from horse spleen; (2) extraction from E. Coli. Currently, there is no existing method for producing co-assembled ferritin heteropolymers, for mammalian and human use, with modifiable ratios of H and L subunits. Technology Overview: This system of expression developed by SUNY Potsdam researchers makes it possible to produce human isoferritins at different desired H-to-L ratios. Different ferritin chains are placed in the same vector, but under the control of different inducible promoters. This method enables the cloning of recombinant ferritin in the pWUR 1+2 tet0 mut89 plasmid. This technology comprises two interrelated methods for cloning ferritin subunits. Advantages:
Allows for scalable isoferitin manufacturing
Enables commercialization of isoferritin to meet increasing demand
Production at various ratios allows for further studies into human isoferritins
Applications
Biomedical Science and Engineering
Medical Devices
Drug Delivery
Intellectual Property Summary: US Provisional Filed 62/963,758 Licensing Potential: Development partner, Commercial partner, Licensing Licensing Status: This technology is available for licensing. https://suny.technologypublisher.com/files/sites/250-2074.jpg
Patent Information:
Title
App Type
Country
Serial No.
Patent No.
File Date
Issued Date
Expire Date
Direct Link:
https://canberra-ip.technologypublisher.com/tech/Expression_of_Human_Isoferritins
Keywords:
Bookmark this page
Download as PDF
For Information, Contact:
Mahfuz Miah
Life Sciences Business Development Associate
The Research Foundation for The State University of New York
518-434-7278
mahfuz.miah@rfsuny.org